Cargando…

Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

A high proportion of patients with coronavirus disease 2019 (COVID-19) experience post-acute COVID-19, including neuropsychiatric symptoms. Objective signs of central nervous system (CNS) damage can be investigated using CNS biomarkers such as glial fibrillary acidic protein (GFAp), neurofilament li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bark, Lovisa, Larsson, Ing-Marie, Wallin, Ewa, Simrén, Joel, Zetterberg, Henrik, Lipcsey, Miklos, Frithiof, Robert, Rostami, Elham, Hultström, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423244/ https://www.ncbi.nlm.nih.gov/pubmed/37573366 http://dx.doi.org/10.1038/s41598-023-39698-y

Ejemplares similares

Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19
por: Hultström, Michael, et al.
Publicado: (2021)

Intensive care‐treated COVID‐19 patients’ perception of their illness and remaining symptoms
por: Wallin, Ewa, et al.
Publicado: (2021)

Poor long-term recovery after critical COVID-19 during 12 months longitudinal follow-up()
por: Larsson, Ing-Marie, et al.
Publicado: (2023)

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

The swedish covid‐19 intensive care cohort: Risk factors of ICU admission and ICU mortality
por: Ahlström, Björn, et al.
Publicado: (2021)

A comparison of impact of comorbidities and demographics on 60-day mortality in ICU patients with COVID-19, sepsis and acute respiratory distress syndrome
por: Ahlström, Björn, et al.
Publicado: (2022)

Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels
por: Camara-Lemarroy, Carlos, et al.
Publicado: (2022)

Health-related quality of life after surviving intensive care for COVID-19: a prospective multicenter cohort study
por: Halvorsen, Peter, et al.
Publicado: (2023)

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study
por: Frithiof, Robert, et al.
Publicado: (2021)

Plasma Leptin Is Increased in Intensive Care Patients with COVID-19—An Investigation Performed in the PronMed-Cohort
por: Larsson, Anders, et al.
Publicado: (2021)

Emergence delirium and postoperative delirium associated with high plasma NfL and GFAP: an observational study
por: Liu, Xingyang, et al.
Publicado: (2023)

Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19
por: Larsson, Anders O., et al.
Publicado: (2022)

Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study
por: Sancho Ferrando, Elena, et al.
Publicado: (2022)

Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury
por: Sass, Dilorom, et al.
Publicado: (2021)

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis
por: Barro, Christian, et al.
Publicado: (2022)

NfL as a biomarker for neurodegeneration and survival in Parkinson disease
por: Bäckström, David, et al.
Publicado: (2020)

Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
por: Larsson, Anders O., et al.
Publicado: (2022)

Estimated glomerular filtration rates are higher when creatinine‐based equations are compared with a cystatin C‐based equation in coronavirus disease 2019
por: Larsson, Anders O., et al.
Publicado: (2022)

The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care
por: Fällmar, David, et al.
Publicado: (2022)

Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients
por: Halbgebauer, Rebecca, et al.
Publicado: (2022)

Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients
por: Ferrari, Federica, et al.
Publicado: (2023)

Prior physical illness predicts death better than acute physiological derangement on intensive care unit admission in COVID-19: A Swedish registry study
por: Stattin, Karl, et al.
Publicado: (2023)

COVID‐19 patients in intensive care develop predominantly oliguric acute kidney injury
por: Luther, Tomas, et al.
Publicado: (2020)

High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19
por: Karawajczyk, Malgorzata, et al.
Publicado: (2021)

Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
por: Baiardi, Simone, et al.
Publicado: (2022)

Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis
por: Yalachkov, Yavor, et al.
Publicado: (2022)

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients
por: Gust, Juliane, et al.
Publicado: (2022)

Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients
por: Frithiof, Robert, et al.
Publicado: (2020)

The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients
por: Järhult, Josef D., et al.
Publicado: (2021)

The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients
por: Berghäll, Elisabeth, et al.
Publicado: (2022)

Correction: Berghäll et al. The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients. Biomedicines 2022, 10, 934
por: Berghäll, Elisabeth, et al.
Publicado: (2023)

Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐olds
por: Dittrich, Anna, et al.
Publicado: (2022)

Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg
por: Dittrich, Anna, et al.
Publicado: (2023)

Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care
por: Asif, Sana, et al.
Publicado: (2020)

Blood type A associates with critical COVID-19 and death in a Swedish cohort
por: Hultström, Michael, et al.
Publicado: (2020)

Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study
por: Galien, Sarah, et al.
Publicado: (2021)

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
por: Schindler, Patrick, et al.
Publicado: (2021)

Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
por: Asif, Sana, et al.
Publicado: (2023)

Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients
por: Bülow Anderberg, Sara, et al.
Publicado: (2021)

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
por: Hansson, Oskar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_isffm2fb8kjduhgce173jqm4uo